Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms (Q24676539)
scientific article
Language:
(P31) (Q13442814)
(P304) 575-84
(P407) (Q1860)
(P433) 8
(P478) 40
(P577) +2003-08-00T00:00:00Z
(P921) (Q852654)
(Q1926345)
(P1433) (Q14640281)
(P1476) "Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms" (language: en)
(P2093) H L Wilson
A C C Wong
S R Shaw
W-Y Tse
G A Stapleton
M C Phelan
S Hu
J Marshall
H E McDermid
(P2860) (Q24563977)
(Q24535749)
(Q22010598)
(Q22003768)
(Q22010466)
(Q24594942)
(Q28205575)
(Q28204585)
(Q28200653)
(Q28145992)
(Q28140303)
(Q28237313)
(Q28235910)
(Q30014842)
(Q34146045)
(Q38490510)
(Q34106222)
(Q33856299)
(Q33892173)
(Q33780781)
(Q35650825)
(Q33681541)
(Q33679238)
(Q35239185)
(Q35888874)
(Q38509518)
(Q35660745)
(Q33874077)
(Q40504423)
(Q33596746)
(Q33593663)
(Q51970717)
(Q47756629)
(Q43787120)
(Q51957535)
(Q52124007)
(Q51962110)
(Q51962113)
(Q51962115)
(Q51965073)
(Q50313091)
(Q48259304)
(Q58194130)
(Q52284695)
(Q71263512)
(Q71433516)
(Q71267623)
(Q68029230)
(Q73209247)
(Q77215833)
(Q76668747)